Picture of Argenica Therapeutics logo

AGN Argenica Therapeutics Balance Sheet

0.000.00%
au flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Annual balance sheet for Argenica Therapeutics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

2020
June 30th
2021
June 30th
2022
June 30th
2023
June 30th
2024
June 30th
Period Length:
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Cash
Cash and Short Term Investments0.3427.148.919.2915.9
Net Total Receivables0.0350.0780.0720.1520.372
Prepaid Expenses
Total Other Current Assets
Total Current Assets0.3777.279.049.5416.4
Net Intangible Assets
Total Assets0.3787.279.049.5416.4
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities0.3590.4260.7361.872.43
Total Long Term Debt
Total Debt
Total Liabilities0.3590.4260.7361.872.43
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity0.0186.858.317.6714
Total Liabilities & Shareholders' Equity0.3787.279.049.5416.4
Total Common Shares Outstanding